chrisvoncsefalvay/vaers-outcomes huggingface dataset:
am unable to go to work, so I am on short-term disability as a result; was at work when I suddenly was unable to stand. I dropped to my knees and started vomiting. I couldn't open my eyes because everything was shaking or moving. I was admitted to emergency room; was at work when I suddenly was unable to stand. I dropped to my knees and started vomiting. I couldn't open my eyes because everything was shaking or moving. I was admitted to emergency room; nauseous.; My vision is still off; could not stand; difficulty talking; This is a spontaneous report from a contactable consumer (patient). A 57-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0169), via an unspecified route of administration, administered in Arm Right on 29Apr2021 15:00 (at the age of 57-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included none. Patient did not have known allergies. Concomitant medication(s) included pantoprazole sodium sesquihydrate (PANTOPRAZOL A) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0151), administered in Arm Right on 08Apr2021 15:00 (at the age of 57-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Patient did not receive any other vaccine in four weeks. The patient stated that on 29Apr2021, he was at work when he suddenly was unable to stand. He dropped to his knees and started vomiting. He could not open his eyes because everything was shaking or moving. He was admitted to emergency room. He could not stand or open his eyes without being nauseous. Everything was still shaking. He had severe vomiting. He was released and sent home. He was unable to stand or open eyes for 48 hours. He had difficulty talking without vomiting. On day 3, he was able to sit up and walk with assistance. He was also slowly able to hold down food. It was day 11 and he was still unsteady on his feet. His vision was still off. It was still very hard to focus. He was unable to go to work, so was on short-term disability as a result. Patient did not have covid prior vaccination and covid was not tested post vaccination. Patient did not receive any treatment. The outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Redness wrapping around the circumference of pt's arm at level of elbow (band is about 6inches in width), itchy, fever of 100 degrees for 12hrs.   Pt took OTC Zyrtec and applied cool compress to site.  Symptoms are slowly resolving, not completely gone yet.
Pt became dizzy approx 5 min after receiving the injection. Her stomach was also upset and she complained of a headache. She appeared pale and limp when I had her rest on a mat. BP 112/72 home with dad feeling better @ 11:30.
Rash on face, neck, chest, back, and lower arm, appeared 11 days after vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) in the arm left on 04Apr2021 at 10:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and cephalosporin. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL) taken for an unknown indication from an unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021, 11 days after vaccination, the patient experienced rash on face, neck, chest, back, and lower arm. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with creams for  the rash. The clinical outcome of the event rash on face, neck, chest, back, and lower arm was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Began having high blood pressure within a month of vaccine. Blood pressure has never been anything but low/normal before now.
arm soreness and chills after a Moderna COVID-19 vaccine; arm soreness and chills after a Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness and chills after a Moderna COVID-19 vaccine) and CHILLS (arm soreness and chills after a Moderna COVID-19 vaccine) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness and chills after a Moderna COVID-19 vaccine) and CHILLS (arm soreness and chills after a Moderna COVID-19 vaccine). At the time of the report, PAIN IN EXTREMITY (arm soreness and chills after a Moderna COVID-19 vaccine) and CHILLS (arm soreness and chills after a Moderna COVID-19 vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Hallucinations during evening for 2 hours after- saw things in his bed and room.
irritation rather than a real cough; dry cough, cough is lingering; feels like I am at the end of a cold; little bit queasy; fatigued; muscle pain, felt like someone punch me in the arm twice; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROAT IRRITATION (irritation rather than a real cough), COUGH (dry cough, cough is lingering), MALAISE (feels like I am at the end of a cold), MYALGIA (muscle pain, felt like someone punch me in the arm twice) and NAUSEA (little bit queasy) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 24-Feb-2021, the patient experienced MYALGIA (muscle pain, felt like someone punch me in the arm twice). On 25-Feb-2021, the patient experienced NAUSEA (little bit queasy) and FATIGUE (fatigued).  On 26-Feb-2021, the patient experienced THROAT IRRITATION (irritation rather than a real cough), COUGH (dry cough, cough is lingering) and MALAISE (feels like I am at the end of a cold). On 26-Feb-2021, NAUSEA (little bit queasy) and FATIGUE (fatigued) had resolved.   On 27-Feb-2021, MYALGIA (muscle pain, felt like someone punch me in the arm twice) had resolved. At the time of the report, THROAT IRRITATION (irritation rather than a real cough), COUGH (dry cough, cough is lingering) and MALAISE (feels like I am at the end of a cold) had not resolved.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-034373 (Patient Link).
flush; dizzy; After receiving the vaccine the blood pressure was 130/78; nauseous; was not able to stand; not feeling well; does not feel right; had a little panic attack; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 43-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 24Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 43 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLOOD PRESSURE INCREASED (non-serious) with onset 24Oct2023, outcome "recovered", described as "After receiving the vaccine the blood pressure was 130/78"; DIZZINESS (non-serious) with onset 24Oct2023, outcome "recovering", described as "dizzy"; FEELING ABNORMAL (non-serious) with onset 24Oct2023, outcome "recovering", described as "does not feel right"; FLUSHING (non-serious) with onset 24Oct2023, outcome "recovering", described as "flush"; PANIC ATTACK (non-serious) with onset 24Oct2023, outcome "recovering", described as "had a little panic attack"; NAUSEA (non-serious) with onset 24Oct2023, outcome "recovering", described as "nauseous"; MALAISE (non-serious) with onset 24Oct2023, outcome "recovering", described as "not feeling well"; DYSSTASIA (non-serious) with onset 24Oct2023, outcome "recovering", described as "was not able to stand". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of nausea.  Additional information: Nurse Practitioner called regarding a patient in her office that received the Pfizer Covid vaccine, Comirnaty today. reporter stated the patient became flush and dizzy immediately after receiving the vaccine. reporter stated the patient came in with her blood pressure at 109/60, then it went up slightly to 130/78 after the vaccine, and them came down to 100/60 back to her baseline within. Reporter stated the patient was not feeling well and did not feel right and was not able to stand even though the patient was no longer dizzy. Reporter stated that the patient felt like she was unable to stand without falling. Reporter stated she gave the patient Zofran since she was nauseous. Reporter stated she believed the blood pressure was a reaction to the reaction, since she was not feeling well and had a little panic attack. Reporter stated the patient walked out feeling better after 1 hour of receiving the vaccine, her blood pressure was normal. Reporter stated the patient was a 43 year old female.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Tinnitus developed in both ears within 48 hours.  Never had before.  It?s loud and disturbing.  Vertigo also.
One week after receiving the vaccine I awoke with itchiness around the injection site, but saw no rash.  Two days later there is a 5 cm diameter reddish area with a rash and swelling that is warm to the touch.  I hope this does not prevent me from getting the 2nd dose of the vaccine!
BNT162B2 NOS/ MODERNA COVID-19 VACCINE; She had COVID in Aug; She had COVID in Aug; This is a spontaneous report received from contactable reporter(s) (Nurse and Consumer or other non HCP).  A 62-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Pauciarticular Juvenile Rheum Arthritus" (unspecified if ongoing); "Allergies: D.Farinae Mite Extract" (unspecified if ongoing); "Dog Epithelium Extract 1:10 Vial" (unspecified if ongoing); "Casein 1:100 Vial" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "recovered" and all described as "She had COVID in Aug"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "recovered", described as "BNT162B2 NOS/ MODERNA COVID-19 VACCINE". Clinical course: She had covid in Aug and had to hold her doses for 10 days.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Considering interchange of vaccine, the role of company suspect drug BNT162b2 to all the reported events Drug ineffective and COVID19 cannot be excluded completely. However the contribution of Moderna to the events cannot be excluded,Linked Report(s) : US-PFIZER INC-202200846805 same patient, different drug/event;
her arm is aching; has on and off chills; This is a spontaneous report from a contactable consumer(patient) via pfizer-sponsored program.   A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 11Feb2021 as dose 1, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  On an unspecified date the patient experienced her arm is aching, has on and off chills. She wanted to know if she can take Tylenol or Advil for reported events. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
swelling in his eyes & lips; swelling in his eyes & lips; hoarseness in his throat/hoarse throat and voice; swelling in this neck; little fatigue; This is a spontaneous report from a contactable consumer (patient's wife) reported for a patient. A 74-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER7613, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 22Mar2021 at 10:00 am (age at vaccination was 74 years) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was 74 years) as dose 1, single for COVID-19 immunization and experienced hoarseness in the throat and swelling to eyes and lips and neck. The vaccine was not administered at facility. There was no history of any previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines were administered on same date of the Pfizer suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the Pfizer-BioNTech COVID-19 Vaccine second dose last Monday, 22Mar2021. On 25Mar2021 at 3:00 am (morning), the patient had some swelling in his eyes & lips, hoarseness in his throat/hoarse throat and voice and swelling in his neck. The patient also had a little fatigue but took Benadryl. The patient noticed that he had swelling to his eyes, lips and down on his neck. He had hoarseness in the throat and his voice was also hoarse. The reporter noticed that after she talked to him that morning. He had not had any treatment for that event. That happened before, about 3 weeks ago also but she blamed it on a powerbowl, it had seaweed and all kinds of stuff like that in it for health, she just dismissed it. Now it had happened again. The reporter asked, that may not be related, but if it was, it would be a relief and wanted to know when one gets the COVID shot was it possible to get the reaction several days after. The patient had that reaction about 3 weeks ago for him but the reporter didn't document it then. The reporter wasn't sure if this was related to the vaccine but she thought it was weird. The reporter added that they both took Benadryl when they got home on 22Mar2021 after both receiving the second vaccine dose. The adverse events did not require a visit to Emergency Room or Physician Office. No relevant tests were done. The outcome of the events was resolving.  No follow-up attempts are possible. No further information is expected.
rapid heart rate; ears ringing; itchiness; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (rapid heart rate), TINNITUS (ears ringing), VACCINATION SITE PRURITUS (itchiness), HEADACHE (headache) and CHILLS (chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (rapid heart rate), TINNITUS (ears ringing), VACCINATION SITE PRURITUS (itchiness), HEADACHE (headache) and CHILLS (chills). The patient was treated with ALPRAZOLAM (XANAX) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, TACHYCARDIA (rapid heart rate), TINNITUS (ears ringing), VACCINATION SITE PRURITUS (itchiness), HEADACHE (headache) and CHILLS (chills) outcome was unknown.            No relevant concomitant medications reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-033650 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Non-significant follow up added. Updated E-mail address.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-033650:first dose
Developed severe lethargy, chills, fatigue. After feeling this way, 1-2 weeks later, I got labs which indicated severe AKI and I was hospitalized for 30 hours and given fluids. Fortunately, I have near resolution of kidney function at this time.
Fainted while standing in line to check-out minutes after getting the vaccine; Blood pressure was low so transported by med unit; Laceration on the bottom of chin and chipped two front top teeth; IV was started on scene to administer fluids.
15 minutes after vaccine developed right side jaw pain followed by vision changes- unable to focus and memory loss of phone numbers etc. reports when she stepped backwards she felt like she was stepping in a hole.  Symptoms resolved in 5 hours.
p/vax pt started jerking, none responsive for several min per mom, urinated during episode, BP taking 90/60. 10 min later BP 96/60, alert sitting up
On the evening of 2/9 I noticed a red patch around the injection area.  It cleared up by the evening of 2/10.  It felt warm but it was not painful or itchy. It was about 2 inches wide by 4 inches long.
"I got an H1N1 vaccination & got an itchy rash all over my body lasting 3 weeks on going. Other students have told me they had the same reaction."
Pt of 5 years and 8 months of age was administered the adult Hep A instead of child / adolescent. This was a 2nd dose of the Hep A.  (The first dose was given elsewhere.) Spoke with mother of pt  and no one had any problems post vax.
pt had moderna for her 1st 2 covid  vaccines and chose to 'boost' w/ pfizer -- she did not have any problems or side effects from either of those doses -- approximately 10 min after receiving her pfizer booster she noted tingling  in her lips -- she immediately took 2 of her benadryl tabs -- 15min later she said her s/s were better/improved and 30min later stated s/s had cleared/resolved -- we watched pt for an hour and was feeling fine/normal when she left.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with improperly stored M-M-R II rHA lot number N014482 with expiration date of 10-MAY-2019 for prophylaxis (dose, route of administration and anatomical location were not reported) and merck sterile diluent for prophylaxis (lot number and expiration date were not reported). No adverse effects were reported. The vaccine was exposed to a temperature excursion 47.3F for 50 minutes and 34.9F for 1 hour. There was previous temperature excursion reported as 47.5F 48 minutes and 35.4F for 30 minutes. A "data logger" was involved. This is one of several cases received from the same reporter. Sender's Comments: US-009507513-1810USA003389: US-009507513-1810USA002882.
Employee agreed to receive the HEPATITIS B vaccine in HEPATIITIS B Vaccination Program.  7/10/2009 10:00 am Employee received the HEPATITIS B vaccine (first shot) by a BCP nurse.  Per the nurse, employee appeared anxious and worried prior to being given the shot.  Shot was administered without incident.  10:50 Employee reported dizziness, nausea, and mild tightness in the epigastric area to the nurse.  Employee was evaluated by BCP physician.  Vaccination site on the left upper arm had no local reaction.  Employee reported no difficulty breathing.  Physical exam was normal including lung exam (no evidence of wheezing).  Employee was given oral hydration, kept under MD observation, and vitals were checked every 10 minutes.  Vitals remained stable.  11:30 Employee reported feeling much better and she felt well enough to back to work under the supervision of Dr.  14:00 Physician examined employee again.  Employee had some erythema on her left upper arm and a micropapular rash on the left elbow (distal to the vaccination site), neck, and right arm.  Employee reported that she did have poison oak earlier in the week but that had been resolving.  Employee reported no difficulty breathing and no other symptoms besides nausea.  Employee advised to go home (and take BENEDRYL) and to go to urgent care/ER if symptoms worsened.  19:00 BCP physician followed up with employee.  Employee reported that she took BENEDRYL at home and overall she felt better.  She did not have any new symptoms except for a low grade fever (99.1 degrees F) and some sweating.  Employee advised to go to the ER if symptoms worsened or fever increased.  7/11/2009 Per employee all of her symptoms resolved by the morning of 7/11/09 and she did not require additional medical care.
Per patient, "a rash that covers the entire body". Patient went to ER and received a steroid shot and a script for oral steroids.
extreme arm pain; extreme fatigue; light fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extreme arm pain), FATIGUE (extreme fatigue) and PYREXIA (light fever) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B71A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (extreme arm pain), FATIGUE (extreme fatigue) and PYREXIA (light fever). At the time of the report, PAIN IN EXTREMITY (extreme arm pain), FATIGUE (extreme fatigue) and PYREXIA (light fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication were reported. No treatment information was reported.